Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Current treatments for alopecia show no significant long-term benefits.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.